Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mang-Ji-Shi capsule phase II trial in primary hyperlipidemia
ChiCTR2000035594Phase 2Recruiting
- Sponsor
- Capital Medical University
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mang-ji-shi in familial hyperlipidemia (3 arms), sponsored by Capital Medical University. Primary endpoint: Rate of change of LDL-C from baseline after 12 weeks of treatment. Started Aug 2020; status: recruiting.
02
Drugs
mang-ji-shi
03
Conditions
familial hyperlipidemia
Beyond the preview
Go deeper on ChiCTR2000035594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035594.